Notice Concerning Data Privacy Incident: Please click here for additional details about the incident and the actions NeoGenomics is taking.
Skip to main content
-
Diagnostic Services
- New Tests
- Test Methodologies
-
Specialty Testing
- Hemopathology
- Solid Tumors
- NeoTYPE® Cancer Profiles
- NeoLAB™ Liquid Biopsy
- NCI-MATCH
- Pediatric Oncology
- Hereditary Cancer
- Test Spotlight
- Tech-Only Program
- Get Started with NeoGenomics
-
Pharma Services
- Pharma Services
- Why Choose NeoGenomics
-
Lab Services
- Overview
- Anatomic Pathology
-
MultiOmyx™
- Overview
- Technologies
- Comprehensive Biomarker Profiling
- Applications
- Literature
- Advanced Data Analysis
- Immune Cells
- Poster Download
- FAQs
- Flow Cytometry
- FISH
- Cytogenetics
-
Molecular
- Overview
- Regulated Sequencing
- Sanger Sequencing
- Viral Genotyping
- Bioinformatics Services
- Microbial Identification
- NanoString Services
- Next-Generation Sequencing Services
- qPCR Services
- IVD Services
- Oncology Data Services
- Transfer and Validate Biomarker Assays
- Request More Information
- Test Menu
- Client Services
- Company
- NEOLINK ® LOG IN
Search Form Mobile Toggle
Mobile Menu Toggle
Coronavirus Statement: Clinical and Pharma Clients.
-
NeoGenomics Acquires Oncology Division from Human Longevity for $37 MillionRead More -
A consultative diagnostic solution for complex hematologic malignanciesCOMPASS®
-
NEOGENOMICS NEWSNeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, FloridaRead More
-
PIK3CA CDxInforming a new biomarker-driven strategyfor HR+/HER2- advanced breast cancerMutation Analysis
-
FGFR CDxA Novel Approach to Target Metastatic Urothelial CancerClick Here
-
NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ®Read More
-
NEOGENOMICS NEWSQIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugsRead More
-
CancerTYPE ID®Learn MoreNow also available through NeoGenomics - for unclear or unknown diagnoses in solid tumorsPerformed and billed separately by our contracted reference laboratory, Biotheranostics, Inc.
Close Menu